메뉴 건너뛰기




Volumn 39, Issue 2, 2000, Pages 85-97

Clinical pharmacokinetics of slow release mesalazine

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ACYLTRANSFERASE; COLITOFALK; DRUG METABOLITE; HISTAMINE H2 RECEPTOR ANTAGONIST; MESALAZINE;

EID: 0033823356     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200039020-00001     Document Type: Review
Times cited : (32)

References (86)
  • 1
    • 0032523332 scopus 로고    scopus 로고
    • Significance of galenic preparations for luminal release of 5-aminosalicylic acid in human small intestinal lumen
    • (1998) Med Klin , vol.93 , pp. 294-299
    • Keller, J.1    Goebell, H.2    Klotz, U.3
  • 12
    • 0032217166 scopus 로고    scopus 로고
    • Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD)
    • (1998) J Drug Target , vol.6 , pp. 85-94
    • Leopold, C.S.1    Eikeler, D.2
  • 13
    • 0023100439 scopus 로고
    • Metabolism and urinary excretion of 5-aminosalicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract
    • (1987) Gut , vol.28 , pp. 196-200
    • Myers, B.1    Evans, D.N.W.2    Rhodes, J.B.K.3
  • 15
    • 0026064515 scopus 로고
    • High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans
    • (1991) J Chromatogr , vol.564 , pp. 296-302
    • De Vos, M.1    Verdievel, H.2    Schoonjans, R.3
  • 18
    • 85037934892 scopus 로고
    • Concentrations of 5-ASA and its major metabolite Ac-5-ASA in human intestinal biopsy homogenates [thesis]. Ghent: University of Ghent
    • (1992)
    • De Vos, M.1
  • 30
    • 0021848752 scopus 로고
    • Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis: Studies on rectal absorption and excretion
    • (1985) Gut , vol.26 , pp. 400-405
    • Campieri, M.1    Lanfranchi, G.A.2    Boschi, S.3
  • 36
    • 0025243656 scopus 로고
    • Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: Comparison of intraluminal colonic concentrations, serum values and urinary excretion
    • (1990) Gut , vol.31 , pp. 1271-1276
    • Staerk Laursen, L.1    Stokholm, M.2    Bukhave, K.3
  • 54
    • 0033021470 scopus 로고    scopus 로고
    • Oral delayed-release mesalazine: A review of its use in ulcerative colitis and Crohn's disease
    • (1999) Drugs , vol.57 , pp. 383-408
    • Prakash, A.1    Markham, A.2
  • 56
    • 0032063660 scopus 로고    scopus 로고
    • Dose-ranging study of mesalamine (Pentasa®) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial
    • (1998) Inflamm Bowel Dis , vol.4 , pp. 79-83
    • Hanauer, S.B.1
  • 60
    • 0030045124 scopus 로고    scopus 로고
    • An oral presentation of mesalamine as long-term maintenance therapy for ulcerative colitis: A randomized, placebo-controlled trial
    • (1996) Ann Intern Med , vol.124 , pp. 204-211
  • 66
    • 0031899851 scopus 로고    scopus 로고
    • Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: A randomised double blind placebo controlled multicentre study
    • (1998) Gut , vol.42 , pp. 195-199
    • Marteau, P.1    Crand, J.2    Foucault, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.